Literature DB >> 1674520

CD2 can mediate TCR/CD3-independent T cell activation.

H Ohno1, C Ushiyama, M Taniguchi, R N Germain, T Saito.   

Abstract

T lymphocytes can be activated clonotypically through TCR/CD3 complex or polyclonally via the CD2 molecule. Whether CD2-mediated activation is dependent on TCR/CD3 expression or signaling is controversial. We have re-explored this issue by using a series of CD2-transfected, TCR/CD3 surface membrane-negative human and mouse T cells. Our results clearly show that such T cells can be triggered for IL-2 secretion and increases in intracellular Ca2+ through the CD2 molecule in the absence of surface expression of TCR/CD3 complexes. These responses are only observed when cells express high levels of CD2 and there is a critical threshold of CD2 expression necessary for such activation in the absence of CD3. Concomitant expression of TCR/CD3 complex markedly lowers the level of CD2 required for activation via the latter pathway. These results provide a clear resolution of the controversy concerning the requirement for surface CD3 expression in T cell activation through CD2 and further suggest a possible role for CD2 in activation of TCR/CD3-negative cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674520

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

Authors:  L A Turka; M C Fletcher; N Craighead; C B Thompson; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4+ T cells expressing converged T-cell receptor genes in vitro.

Authors:  Miki Tsuruta; Shohei Ueda; Poh Yin Yew; Isao Fukuda; Sachiko Yoshimura; Hiroyuki Kishi; Hiroshi Hamana; Masatoshi Hirayama; Junji Yatsuda; Atsushi Irie; Satoru Senju; Eiji Yuba; Tomomi Kamba; Masatoshi Eto; Hideki Nakayama; Yasuharu Nishimura
Journal:  Oncoimmunology       Date:  2018-01-05       Impact factor: 8.110

3.  Predominant role of T cell receptor (TCR)-alpha chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system.

Authors:  Tadashi Yokosuka; Kan Takase; Misao Suzuki; Yohko Nakagawa; Shinsuke Taki; Hidemi Takahashi; Takehiko Fujisawa; Hisashi Arase; Takashi Saito
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

4.  The OX-44 molecule couples to signaling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line.

Authors:  G M Bell; W E Seaman; E C Niemi; J B Imboden
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

5.  CD2 sets quantitative thresholds in T cell activation.

Authors:  M F Bachmann; M Barner; M Kopf
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

6.  Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16).

Authors:  L L Spruyt; M J Glennie; A D Beyers; A F Williams
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

7.  Development of a new monoclonal antibody specific to mouse Vγ6 chain.

Authors:  Shinya Hatano; Xin Tun; Naoto Noguchi; Dan Yue; Hisakata Yamada; Xun Sun; Mitsuru Matsumoto; Yasunobu Yoshikai
Journal:  Life Sci Alliance       Date:  2019-05-07

8.  Development and function of T cells in mice with a disrupted CD2 gene.

Authors:  N Killeen; S G Stuart; D R Littman
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Clonotypically similar hybrid αβ T cell receptors can exhibit markedly different surface expression, antigen specificity and cross-reactivity.

Authors:  C Motozono; J S Bridgeman; D A Price; A K Sewell; T Ueno
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.